Early Stage Venture Aegle Therapeutics Raises Series A of $6500000

About Aegle Therapeutics

Aegle Therapeutics is a clinical-stage regenerative medicine company that develops novel therapeutics.

Website: Learn more on Aegle Therapeutics’s website

Crunchbase: Follow on Crunchbase

Series A – Aegle Therapeutics

Amount Raised6500000 USD
Announced Date2020-09-29
Equity Only FundingYes
Organization LocationMiami, Florida, United States, North America
Funding StatusEarly Stage Venture
Number of Funding Rounds3
Lead Investors
Number of Investors5
Number of Partner Investors1

Written by Startup News

Early Stage Venture Snappr Raises Series A of $10000000

Early Stage Venture Sunstone Eduversity Raises Series A of $3263745